首頁 > 市場調查報告書 > 醫療設備

放射腫瘤市場規模、佔有率和成長分析（按類型、應用、最終用戶和地區分類）—產業預測（2026-2033 年）

市場調查報告書

商品編碼

1898365

放射腫瘤市場規模、佔有率和成長分析（按類型、應用、最終用戶和地區分類）—產業預測（2026-2033 年）

Radiation Oncology Market Size, Share, and Growth Analysis, By Type (External Beam Radiation Therapy, Internal Beam Radiation Therapy), By Application (Prostate Cancer, Breast Cancer), By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月24日 | 出版商:

SkyQuest | 英文 172 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，全球放射腫瘤學市場規模將達到 118.1 億美元，到 2025 年將成長至 132.7 億美元，到 2033 年將成長至 335.6 億美元，在預測期（2026-2033 年）內，複合年成長率為 12.3%。

全球放射腫瘤市場正經歷顯著成長，主要促進因素是人口老化、生活方式改變和環境因素導致全球癌症發生率上升。強度調控放射治療放射線手術(SRS) 等放射治療技術的創新顯著提高了治療精確度和病患療效。世界衛生組織 (WHO) 報告稱，每年有數百萬例癌症病例和死亡病例，凸顯了有效治療方案的緊迫性。為此，主要產業參與者正採取策略性措施來鞏固其市場地位，例如近期獲得監管部門核准以及建立旨在推進創新治療方法的合作關係。這種不斷變化的市場格局凸顯了對先進癌症治療方案的明確需求，從而刺激了對各種治療方法的投資和研發。

全球放射腫瘤市場按類型、應用、最終用戶和地區進行細分。依類型分類，可分為體外放射治療和體內放射治療。依應用分類，可分為攝護腺癌、乳癌、肺癌、大腸癌、婦科癌症、子宮頸癌、陰莖癌等癌症。依最終用戶分類，可分為醫院、專科診所及其他機構。按地區分類，可分為北美、歐洲、亞太、中東和非洲以及拉丁美洲。

全球放射腫瘤市場促進因素

全球放射腫瘤市場正經歷顯著成長，這主要得益於全球癌症發生率的不斷攀升。癌症仍然是主要的死亡原因之一，推動了對先進療法（尤其是放射療法）的需求。這種需求的成長促使人們對放射和腫瘤技術進行了大量投資，進一步促進了市場擴張。隨著醫療系統努力拓展治療選擇並改善患者預後，創新放射腫瘤解決方案的持續開發和應用在應對全球癌症發病率不斷上升帶來的挑戰方面發揮關鍵作用。

限制全球放射腫瘤市場發展的因素

全球放射腫瘤市場面臨嚴峻挑戰，主要原因是放射治療及相關設備高成本。放射治療中使用的先進技術價格往往高得令人望而卻步，許多醫療機構，尤其是中低收入地區的醫療機構，難以負擔。這種經濟障礙限制了放射治療在癌症治療中的廣泛應用，最終阻礙了市場的成長和發展。因此，這些醫療資源匱乏地區病患獲得基本放射腫瘤服務的機會有限，進而影響了病患預後的改善。

全球放射腫瘤市場趨勢

全球放射腫瘤學市場的一個顯著趨勢是質子療法的日益普及，這得益於其能夠更精準地靶向癌細胞，並將鄰近健康組織的損傷降至最低。這種創新治療方法不僅改善了某些癌症的治療效果，也滿足了患者對微創治療方法和更少潛在副作用的需求。隨著醫療機構逐漸認知到質子療法的優勢，預計需求將激增，從而推動放射腫瘤技術的持續進步和投資。這一轉變反映了全球腫瘤學領域向個人化醫療和改善患者照護方向發展的更廣泛努力。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Varian Medical Systems, Inc.（Siemens Healthineers AG）（US）
Elekta AB（Sweden）
Accuray Incorporated（US）
IBA Radiopharma Solutions（Belgium）
BD（Becton, Dickinson and Company）（US）
Isoray Inc.（US）
Mevion Medical Systems（US）
Nordion, Inc.（Sotera Health）（Canada）
NTP Radioisotopes SOC Ltd.（South Africa）
Curium（France）
ViewRay Technologies, Inc.（US）
IBA Worldwide（Belgium）
Provision Healthcare（US）
Canon Inc.（Japan）
Hitachi Ltd.（Japan）
Icad Inc.（US）
Ion Beam Applications（Belgium）
Panacea Medical Technologies Pvt. Ltd.（India）
P-Cure Ltd.（Israel）

結論與建議

簡介目錄

Product Code: SQMIG35A2944

Global Radiation Oncology Market size was valued at USD 11.81 Billion in 2024 and is poised to grow from USD 13.27 Billion in 2025 to USD 33.56 Billion by 2033, growing at a CAGR of 12.3% during the forecast period (2026-2033).

The global radiation oncology market is witnessing substantial growth, primarily fueled by the rising incidence of cancer globally due to an aging population, lifestyle changes, and environmental factors. Breakthroughs in radiation therapy technologies, such as intensity-modulated radiation therapy and stereotactic radiosurgery, have significantly improved treatment precision and patient outcomes. The World Health Organization reports millions of cancer cases and deaths annually, indicating an urgent need for effective treatment solutions. In response, key industry players are implementing strategic initiatives to strengthen their market positions, exemplified by recent regulatory approvals and collaborations aimed at advancing innovative therapies. This evolving landscape highlights a clear demand for enhanced oncology solutions, driving investment and development in diverse therapeutic approaches.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Radiation Oncology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Radiation Oncology Market Segments Analysis

Global Radiation Oncology Market is segmented on the type, application, end user, and region. By type, market is segmented into External Beam Radiation Therapy, and Internal Beam Radiation Therapy. By application, market is segmented into Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Gynecological Cancer, Cervical Cancer, Penile Cancer, and Others. By end user, market is segmented into Hospitals, Specialty Clinics, and Others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Driver of the Global Radiation Oncology Market

The global radiation oncology market is experiencing significant growth, primarily fueled by the rising prevalence of cancer across the world. As cancer remains a leading cause of mortality, there is an escalating demand for advanced treatments, particularly radiation therapy. This growing need has prompted substantial investments in radiation and oncology technologies, further contributing to the market's expansion. As healthcare systems strive to enhance treatment options and improve patient outcomes, the continuous development and adoption of innovative radiation oncology solutions play a crucial role in addressing the challenges posed by increasing cancer rates globally.

Restraints in the Global Radiation Oncology Market

The global radiation oncology market faces significant challenges due to the high costs associated with radiation therapy and its related equipment. The advanced technologies utilized in radiation therapy often come with substantial price tags, rendering them unaffordable for numerous healthcare providers, particularly in low- and middle-income regions. This financial barrier restricts the broader implementation of radiation treatment for cancer, ultimately impeding the growth and development of the market. As a result, the limited accessibility to essential radiation oncology services hinders the potential for improving patient outcomes in these underserved areas.

Market Trends of the Global Radiation Oncology Market

A significant trend in the Global Radiation Oncology market is the rising adoption of proton therapy, driven by its enhanced precision in targeting malignant cells while minimizing harm to adjacent healthy tissues. This innovative approach not only improves treatment outcomes for specific cancers but also appeals to patients seeking less invasive options with potentially fewer side effects. As healthcare providers increasingly recognize the benefits of proton therapy, demand is expected to surge, catalyzing ongoing advancements and investments in radiation oncology technologies. This shift reflects a broader commitment to personalized medicine and improved patient care in oncology practices worldwide.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index, 2025
PESTEL Analysis
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape
Technology Assessment

Global Radiation Oncology Market Size by Type & CAGR (2026-2033)

Market Overview
External Beam Radiation Therapy
Internal Beam Radiation Therapy

Global Radiation Oncology Market Size by Application & CAGR (2026-2033)

Market Overview
Prostate Cancer
Breast Cancer
Lung Cancer
Colorectal Cancer
Gynecological Cancer
Cervical Cancer
Penile Cancer
Others

Global Radiation Oncology Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Specialty Clinics
Others

Global Radiation Oncology Market Size & CAGR (2026-2033)

North America (Type, Application, End User)
- US
- Canada
Europe (Type, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Application, End User)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Varian Medical Systems, Inc. (Siemens Healthineers AG) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elekta AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Accuray Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IBA Radiopharma Solutions (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BD (Becton, Dickinson and Company) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Isoray Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mevion Medical Systems (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nordion, Inc. (Sotera Health) (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NTP Radioisotopes SOC Ltd. (South Africa)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Curium (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ViewRay Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IBA Worldwide (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Provision Healthcare (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Canon Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hitachi Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Icad Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ion Beam Applications (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Panacea Medical Technologies Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
P-Cure Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments